NCT00122720 The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery Status COMPLETED Phase PHASE4
NCT00121628 A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer Status COMPLETED Phase PHASE2
NCT00121615 Study of Etanercept in the Treatment of Psoriasis in Adult Subjects Status COMPLETED Phase PHASE3
NCT00121602 Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease Status COMPLETED Phase PHASE3
NCT00121056 REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations Status COMPLETED Phase N/A
NCT00121043 Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire Status COMPLETED Phase PHASE4
NCT00121030 Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy Status COMPLETED Phase PHASE2
NCT00120705 Treatment for Anemic Subjects With Non-Myeloid Malignancies Receiving Chemotherapy Status COMPLETED Phase PHASE2
NCT00120692 Treatment for Patients Suffering From Anemia Due to Chemotherapy Status COMPLETED Phase PHASE2
NCT00120679 Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy Status COMPLETED Phase PHASE2
NCT00119613 A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa Status COMPLETED Phase PHASE3
NCT00119600 A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy Status TERMINATED Phase PHASE1/PHASE2
NCT00119587 Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects Status COMPLETED Phase PHASE3
NCT00118638 A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy Status COMPLETED Phase PHASE3
NCT00117910 Treatment for Elderly Patients With High Risk Breast Cancer Status COMPLETED Phase PHASE3
NCT00117624 A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy Status COMPLETED Phase PHASE3
NCT00117455 A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00117442 A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood Status COMPLETED Phase PHASE2